Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Discover various wealth accumulation methods and strategies to enhance your financial growth. Start implementing them now.
28,655 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
Prediction markets are pricing a surprisingly small cost for a big Bitcoin bet. This article explains what traders pa...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Income investors are eyeing a familiar Dividend King delivering a near-3% yield. This article breaks down what that s...
A new chapter opens at Berkshire Hathaway as Warren Buffett's successor, Greg Abel, reshapes the portfolio. From bold...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Industry lenders are speeding toward AI-driven processes in reverse mortgage operations, but legal experts warn that ...
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
Palantir has won a landmark Army data overhaul deal worth $10 billion, signaling a decade-long shift in defense IT an...
A rising wave in artificial intelligence memory is reshaping tech demand. Learn how to profit with under $100 through...
Jamie Dimon's JPMorgan Chase just delivered a striking quarterly message: big gains in equities trading and a higher ...